Paper9502779
Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.
Khatri VP and 9 others. J Clin Invest, 1998. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. Papers, record 9502779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9502779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| Interferon-gamma | Major topic |
| Interleukin-2 | Major topic |
| Lymphoma, AIDS-Related | Major topic |
| Sarcoma, Kaposi | Major topic |
| CD4 Lymphocyte Count | |
| CD8-Positive T-Lymphocytes | |
| Flow Cytometry | |
| Gene Expression | |
| Humans | |
| Immunity, Innate | |
| Immunocompromised Host | |
| Immunotherapy | |
| Interleukin-10 | |
| Killer Cells, Natural | |
| Leukocytes, Mononuclear | |
| Lipopolysaccharides | |
| Lymphocyte Count | |
| Polymerase Chain Reaction | |
| T-Lymphocyte Subsets |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-09581 | NCI NIH HHS | United States | T32CA009581 | PubMed and NIH | NIH RePORTER |
| CA-68456 | NCI NIH HHS | United States | PubMed | PubMed | |
| P30CA-16058 | NCI NIH HHS | United States | P30CA016058 | PubMed and NIH | NIH RePORTER |
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7559914 | Biology of human TH1 and TH2 cells. | J Clin Immunol | 1995 | https://conductscience.org/library/papers/7559914 | PubMed |
| 2 | 7579429 | Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. | Blood | 1995 | https://conductscience.org/library/papers/7579429 | PubMed |
| 3 | 8739561 | Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement. | Immunol Res | 1996 | https://conductscience.org/library/papers/8739561 | PubMed |
| 4 | 8816813 | Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8816813 | PubMed |
| 5 | 8820272 | The expanding universe of T-cell subsets: Th1, Th2 and more. | Immunol Today | 1996 | https://conductscience.org/library/papers/8820272 | PubMed |
| 6 | 8960473 | A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8960473 | PubMed |
| 7 | 8960475 | Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8960475 | PubMed |
| 8 | 9022011 | Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. | Eur J Immunol | 1997 | https://conductscience.org/library/papers/9022011 | PubMed |
| 9 | 9028322 | Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. | Blood | 1997 | https://conductscience.org/library/papers/9028322 | PubMed |
| 10 | 9045904 | CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. | Eur J Immunol | 1997 | https://conductscience.org/library/papers/9045904 | PubMed |
| 11 | 9142122 | HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. | Nat Med | 1997 | https://conductscience.org/library/papers/9142122 | PubMed |
| 12 | 1352911 | Programmed death of T cells in HIV-1 infection. | Science | 1992 | https://conductscience.org/library/papers/1352911 | PubMed |
| 13 | 8426121 | Interferon gamma inhibits interleukin 10 production by monocytes. | J Exp Med | 1993 | https://conductscience.org/library/papers/8426121 | PubMed |
| 14 | 8097322 | Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8097322 | PubMed |
| 15 | 8100999 | Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8100999 | PubMed |
| 16 | 8102262 | The T cell receptor V beta repertoire in HIV-1 infection and disease. | Semin Immunol | 1993 | https://conductscience.org/library/papers/8102262 | PubMed |
| 17 | 8409467 | Constructing polycompetitor cDNAs for quantitative PCR. | J Immunol Methods | 1993 | https://conductscience.org/library/papers/8409467 | PubMed |
| 18 | 8216925 | The role of natural killer cells in innate resistance to infection. | Curr Opin Immunol | 1993 | https://conductscience.org/library/papers/8216925 | PubMed |
| 19 | 8228800 | Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. | J Exp Med | 1993 | https://conductscience.org/library/papers/8228800 | PubMed |
| 20 | 8235617 | Multifactorial nature of human immunodeficiency virus disease: implications for therapy. | Science | 1993 | https://conductscience.org/library/papers/8235617 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33233727 | The Mediation of miR-34a/miR-449c for Immune Cytokines in Acute Cold/Heat-Stressed Broiler Chicken. | Animals (Basel) | 2020 | https://conductscience.org/library/papers/33233727 | PubMed |
| 33102204 | Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals. | Front Oncol | 2020 | https://conductscience.org/library/papers/33102204 | PubMed |
| 31989589 | Low-dose IL-2 induces CD56bright NK regulation of T cells via NKp44 and NKp46. | Clin Exp Immunol | 2020 | https://conductscience.org/library/papers/31989589 | PubMed |
| 26729100 | Astaxanthin, a Carotenoid, Stimulates Immune Responses by Enhancing IFN-γ and IL-2 Secretion in Primary Cultured Lymphocytes in Vitro and ex Vivo. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/26729100 | PubMed |
| 25054077 | Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer. | Scientifica (Cairo) | 2014 | https://conductscience.org/library/papers/25054077 | PubMed |
| 18698048 | Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18698048 | PubMed |
| 18171294 | Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2. | J Infect Dis | 2008 | https://conductscience.org/library/papers/18171294 | PubMed |
| 16474159 | Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall. | J Virol | 2006 | https://conductscience.org/library/papers/16474159 | PubMed |
| 10880055 | Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10880055 | PubMed |
| 10051630 | Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10051630 | PubMed |
| 9767056 | Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. | Clin Microbiol Rev | 1998 | https://conductscience.org/library/papers/9767056 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9502779
GET https://conductscience.org/api/papers/v1/9502779/references?page=2